Telix Pharmaceuticals Ltd
ASX:TLX

Watchlist Manager
Telix Pharmaceuticals Ltd Logo
Telix Pharmaceuticals Ltd
ASX:TLX
Watchlist
Price: 22.58 AUD 1.71% Market Closed
Market Cap: 7.6B AUD
Have any thoughts about
Telix Pharmaceuticals Ltd?
Write Note

Wall Street
Price Targets

TLX Price Targets Summary
Telix Pharmaceuticals Ltd

Wall Street analysts forecast TLX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLX is 26.46 AUD with a low forecast of 21.82 AUD and a high forecast of 35.07 AUD.

Lowest
Price Target
21.82 AUD
3% Downside
Average
Price Target
26.46 AUD
17% Upside
Highest
Price Target
35.07 AUD
55% Upside
Telix Pharmaceuticals Ltd Competitors:
Price Targets
IDYA
IDEAYA Biosciences Inc
108% Upside
SGMT
Sagimet Biosciences Inc
639% Upside
301301
Yili Chuanning Biotechnology Co Ltd
17% Downside
068270
Celltrion Inc
44% Upside
NVAX
Novavax Inc
106% Upside
ORY
Oryzon Genomics SA
296% Upside
TNGX
Tango Therapeutics Inc
200% Upside
EXAI
Exscientia PLC
13% Upside

Revenue
Forecast

Revenue Estimate
Telix Pharmaceuticals Ltd

For the last 5 years the compound annual growth rate for Telix Pharmaceuticals Ltd's revenue is 381%. The projected CAGR for the next 3 years is 39%.

381%
Past Growth
39%
Estimated Growth
Estimates Accuracy
-41%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Telix Pharmaceuticals Ltd

The compound annual growth rate of Telix Pharmaceuticals Ltd's operating income for the next 3 years is 164%.

N/A
Past Growth
164%
Estimated Growth
Estimates Accuracy
29%
Average Beat

Net Income
Forecast

Net Income Estimate
Telix Pharmaceuticals Ltd

The compound annual growth rate of Telix Pharmaceuticals Ltd's net income for the next 3 years is 234%.

N/A
Past Growth
234%
Estimated Growth
Estimates Accuracy
8%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TLX's stock price target?
Price Target
26.46 AUD

According to Wall Street analysts, the average 1-year price target for TLX is 26.46 AUD with a low forecast of 21.82 AUD and a high forecast of 35.07 AUD.

What is Telix Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
39%

For the last 5 years the compound annual growth rate for Telix Pharmaceuticals Ltd's revenue is 381%. The projected CAGR for the next 3 years is 39%.

What is Telix Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
164%

The compound annual growth rate of Telix Pharmaceuticals Ltd's operating income for the next 3 years is 164%.

What is Telix Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
234%

The compound annual growth rate of Telix Pharmaceuticals Ltd's net income for the next 3 years is 234%.

Back to Top